Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study.

Kidney360 · 2024 · PMC11219110 · PMID 38622759

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Despite high screen failure and small sample size, a nominally significant increase in sHCO 3 – was seen for sodium zirconium cyclosilicate versus placebo.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.